Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Interest Coverage Ratio (2016 - 2026)

Amphastar Pharmaceuticals has reported Interest Coverage Ratio over the past 13 years, most recently at 11.89 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio fell 269.23% year-over-year to 11.89; the TTM value through Dec 2025 reached 1.02, down 84.95%, while the annual FY2025 figure was 1.02, 84.95% down from the prior year.
  • Interest Coverage Ratio for Q4 2025 was 11.89 at Amphastar Pharmaceuticals, down from 4.03 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 144.36 in Q4 2021 and troughed at 11.89 in Q4 2025.
  • A 5-year average of 39.35 and a median of 9.38 in 2023 define the central range for Interest Coverage Ratio.
  • Biggest five-year swings in Interest Coverage Ratio: skyrocketed 341.24% in 2021 and later tumbled 269.23% in 2025.
  • Year by year, Interest Coverage Ratio stood at 144.36 in 2021, then plummeted by 50.37% to 71.65 in 2022, then plummeted by 92.03% to 5.71 in 2023, then increased by 23.08% to 7.03 in 2024, then crashed by 269.23% to 11.89 in 2025.
  • Business Quant data shows Interest Coverage Ratio for AMPH at 11.89 in Q4 2025, 4.03 in Q3 2025, and 6.72 in Q2 2025.